Efficient mother-to-child transfer of antiretroviral immunity in the context of preclinical monoclonal antibody-based immunotherapy

Journal of Virology

Volumn 80, Issue 20, 2006, Pages 10191-10200

  Gros, Laurent ^a   Pelegrin, Mireia ^a   Plays, Marc ^a   Piechaczyk, Marc ^a  

^a CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIVIRAL ACTIVITY; ARTICLE; BREAST FEEDING; CONTROLLED STUDY; HUMORAL IMMUNITY; IMMUNOTHERAPY; MOTHER CHILD RELATION; MOUSE; NEWBORN INFECTION; NONHUMAN; PASSIVE IMMUNIZATION; PLACENTAL TRANSFER; PREGNANCY; PRIORITY JOURNAL; RETROVIRUS INFECTION; VIREMIA; VIRUS IMMUNITY; VIRUS LOAD; VIRUS NEUTRALIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BREAST FEEDING; DISEASE MODELS, ANIMAL; DNA, VIRAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; IMMUNOLOGIC FACTORS; MICE; NEURODEGENERATIVE DISEASES; NEUTRALIZATION TESTS; PREGNANCY; RETROVIRIDAE; RETROVIRIDAE INFECTIONS; SPLEEN; VIREMIA;

ANIMALIA;

EID: 33749456271     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01095-06     Document Type: Article

References (35)

1. Baba, T. W., V. Liska, R. Hofmann-Lehmann, J. Vlasak, W. Xu, S. Ayehunie, L. A. Cavacini, M. R. Posner, H. Katinger, G. Stiegler, B. J. Bernacky, T. A. Rizvi, R. Schmidt, L. R. Hill, M. E. Keeling, Y. Lu, J. E. Wright, T. C. Chou, and R. M. Ruprecht. 2000. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat. Med. 6:200-206.
2. Bulterys, M., and P. Lepage. 1998. Mother-to-child transmission of HIV. Curr. Opin. Pediatr. 10:143-150.
3. Chappuis, G. 1998. Neonatal immunity and immunisation in early age: lessons from veterinary medicine. Vaccine 16:1468-1472.
4. Cleary, T. G. 2004. Human milk protective mechanisms. Adv. Exp. Med. Biol. 554:145-154.
5. Czub, S., W. P. Lynch, M. Czub, and J. L. Portis. 1994. Kinetic analysis of spongiform neurodegenerative disease induced by a highly virulent murine retrovirus. Lab. Investig. 70:711-723.
6. Dagan, S., and R. Eren. 2003. Therapeutic antibodies against viral hepatitis. Curr. Opin. Mol. Ther. 5:148-155.
7. Dreja, H., L. Gros, S. Villard, E. Bachrach, A. Oates, C. Granier, T. Chardes, J. C. Mani, M. Piechaczyk, and M. Pelegrin. 2003. Monoclonal antibody 667 recognizes the variable region A motif of the ecotropic retrovirus CasBrE envelope glycoprotein and inhibits Env binding to the viral receptor. J. Virol. 77:10984-10993.
8. Englund, J., W. P. Glezen, and P. A. Piedra. 1998. Maternal immunization against viral disease. Vaccine 16:1456-1463.
9. Evans, L. H., R. P. Morrison, F. G. Malik, J. Portis, and W. J. Britt. 1990. A neutralizable epitope common to the envelope glycoproteins of ecotropic, polytropic, xenotropic, and amphotropic murine leukemia viruses. J. Virol. 64:6176-6183.
10. Feeney, M. E. 2004. HIV and children: the developing immune system fights back. West Indian Med. J. 53:359-362.
11. Feeney, M. E., Y. Tang, K. Pfafferott, K. A. Roosevelt, R. Draenert, A. Trocha, X. G. Yu, C. Verrill, T. Allen, C. Moore, S. Mallal, S. Burchett, K. McIntosh, S. I. Pelton, M. A. St John, R. Hazra, P. Klenerman, M. Altfeld, B. D. Walker, and P. J. Goulder. 2005. HIV-1 viral escape in infancy followed by emergence of a variant-specific CTL response. J. Immunol. 174:7524-7530.
12. Ferrantelli, F., R. A. Rasmussen, K. A. Buckley, P. L. Li, T. Wang, D. C. Montefiori, H. Katinger, G. Stiegler, D. C. Andersen, H. M. McClure, and R. M. Ruprecht. 2004. Complete protection of neonatal rhesus macaques against oral exposure to pathogenic simian-human immunodeficiency virus by human anti-HIV monoclonal antibodies. J. Infect. Dis. 189:2167-2173.
13. Gros, L., H. Dreja, A. L. Fiser, M. Plays, M. Pelegrin, and M. Piechaczyk. 2005. Induction of long-term protective antiviral endogenous immune response by short neutralizing monoclonal antibody treatment. J. Virol. 79:6272-6280.
14. Haigwood, N. L., D. C. Montefiori, W. F. Sutton, J. McClure, A. J. Watson, G. Voss, V. M. Hirsch, B. A. Richardson, N. L. Letvin, S. L. Hu, and P. R. Johnson. 2004. Passive immunotherapy in simian immunodeficiency virus-infected macaques accelerates the development of neutralizing antibodies. J. Virol. 78:5983-5995.
15. Haynes, B. F., J. Fleming, E. W. St Clair, H. Katinger, G. Stiegler, R. Kunert, J. Robinson, R. M. Scearce, K. Plonk, H. F. Staats, T. L. Ortel, H. X. Liao, and S. M. Alam. 2005. Cardiolipin polyspecific autoreactivity in two broadly neutralizing HIV-1 antibodies. Science 308:1906-1908.
16. John, G. C., and J. Kreiss. 1996. Mother-to-child transmission of human immunodeficiency virus type 1. Epidemiol. Rev. 18:149-157.
17. Lynch, W. P., S. Czub, F. J. McAtee, S. F. Hayes, and J. L. Portis. 1991. Murine retrovirus-induced spongiform encephalopathy: productive infection of microglia and cerebellar neurons in accelerated CNS disease. Neuron 7:365-379.
18. Manz, R. A., A. E. Hauser, F. Hiepe, and A. Radbruch. 2005. Maintenance of serum antibody levels. Annu. Rev. Immunol. 23:367-386.
19. Mc Cann, C. M., R. J. Song, and R. M. Ruprecht. 2005. Antibodies: can they protect against HIV infection? Curr. Drug Targets Infect. Disord. 5:95-111.
20. McAtee, F. J., and J. L. Portis. 1985. Monoclonal antibodies specific for wild mouse neurotropic retrovirus: detection of comparable levels of virus replication in mouse strains susceptible and resistant to paralytic disease. J. Virol. 56:1018-1022.
21. Nakowitsch, S., H. Quendler, H. Fekete, R. Kunert, H. Katinger, and G. Stiegler. 2005. HIV-1 mutants escaping neutralization by the human antibodies 2F5, 2G12, and 4E10: in vitro experiments versus clinical studies. AIDS 19:1957-1966.
22. Pelegrin, M., M. Marin, A. Oates, D. Noel, R. Saller, B. Salmons, and M. Piechaczyk. 2000. Immunotherapy of a viral disease by in vivo production of therapeutic monoclonal antibodies. Hum. Gene Ther. 11:1407-1415.
23. Portis, J. L., S. Czub, C. F. Garon, and F. J. McAtee. 1990. Neurodegenerative disease induced by the wild mouse ecotropic retrovirus is markedly accelerated by long terminal repeat and Gag-Pol sequences from nondefective Friend murine leukemia virus. J. Virol. 64:1648-1656.
24. Reichert, J. M., C. J. Rosensweig, L. B. Faden, and M. C. Dewitz. 2005. Monoclonal antibody successes in the clinic. Nat. Biotechnol. 23:1073-1078.
25. Rychert, J., and A. M. Amedee. 2005. The antibody response to SIV in lactating rhesus macaques. J. Acquir. Immune Defic. Syndr. 38:135-141.
26. Safrit, J. T., R. Ruprecht, F. Ferrantelli, W. Xu, M. Kitabwalla, K. Van Rompay, M. Marthas, N. Haigwood, J. R. Mascola, K. Luzuriaga, S. A. Jones, B. J. Mathieson, and M. L. Newell. 2004. Immunoprophylaxis to prevent mother-to-child transmission of HIV-1. J. Acquir. Immune Defic. Syndr. 35:169-177.
27. Saha, K., D. Hollowell, and P. K. Wong. 1994. Mother-to-baby transfer of humoral immunity against retrovirus-induced neurologic disorders and immunodeficiency. Virology 198:129-137.
28. Scarlatti, G., J. Albert, P. Rossi, V. Hodara, P. Biraghi, L. Muggiasca, and E. M. Fenyo. 1993. Mother-to-child transmission of human immunodeficiency virus type 1: correlation with neutralizing antibodies against primary isolates. J. Infect. Dis. 168:207-210.
29. Scarlatti, G., T. Leitner, V. Hodara, E. Halapi, P. Rossi, J. Albert, and E. M. Fenyo. 1993. Neutralizing antibodies and viral characteristics in mother-to-child transmission of HIV-1. Aids 7(Suppl. 2):S45-S48.
30. Shah, U., B. L. Dickinson, R. S. Blumberg, N. E. Simister, W. I. Lencer, and W. A. Walker. 2003. Distribution of the IgG Fc receptor, FcRn, in the human fetal intestine. Pediatr. Res. 53:295-301.
31. Siegrist, C. A. 2001. Neonatal and early life vaccinology. Vaccine 19:3331-3346.
32. Simister, N. E. 2003. Placental transport of immunoglobulin G. Vaccine 21:3365-3369.
33. Sitbon, M., J. Nishio, K. Wehrly, D. Lodmell, and B. Chesebro. 1985. Use of a focal immunofluorescence assay on live cells for quantitation of retroviruses: distinction of host range classes in virus mixtures and biological cloning of dual-tropic murine leukemia viruses. Virology 141:110-118.
34. Van de Perre, P. 2003. Transfer of antibody via mother's milk. Vaccine 21:3374-3376.
35. Yorty, J. L., and R. H. Bonneau. 2004. Prenatal transfer of low amounts of HSV-specific antibody protects newborn mice against HSV infection during acute maternal stress. Brain Behav. Immun. 18:15-23.